ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,897Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 1171

$1.69M Total Retail Price of All Prescriptions

Rank: 8 out of 1171

790 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 790 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 790 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 22,746 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

39% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
SIMVASTATIN 1,158 1,111 1 1
AMLODIPINE BESYLATE 1,140 1,121 2 2
ALENDRONATE SODIUM 647 631 3 33
ATORVASTATIN CALCIUM 536 472 4 10
OMEPRAZOLE 495 479 5 5
METOPROLOL SUCCINATE 475 431 6 17
ATENOLOL 474 474 7 15
DIOVAN 472 469 8 32
GLYBURIDE-METFORMIN HCL 448 431 R 9 163
DIOVAN HCT 436 421 10 65
PRAVASTATIN SODIUM 435 405 11 13
METFORMIN HCL 424 403 12 7
LOSARTAN POTASSIUM 423 413 13 14
CRESTOR 419 405 14 27
LISINOPRIL 393 361 15 3
RANITIDINE HCL 335 327 16 38
TAMSULOSIN HCL 317 317 17 28
ZOLPIDEM TARTRATE 282 265 18 21
ACTONEL 281 277 19 212
FUROSEMIDE 270 268 20 6
AZITHROMYCIN 269 249 21 43
CELEBREX 241 228 22 100
LIDODERM 225 210 23 98
LIPITOR 211 200 24 92
NEXIUM 202 183 25 25
CLOPIDOGREL 190 190 26 35
PLAVIX 187 187 27 55
ACETAMINOPHEN-CODEINE 182 170 S3 28 121
LOVAZA 178 178 29 118
BYSTOLIC 174 174 30 96
CIPROFLOXACIN HCL 173 162 31 61
PATANOL 170 158 32 254
FLUTICASONE PROPIONATE 170 167 32 30
PANTOPRAZOLE SODIUM 170 165 32 29
GLIMEPIRIDE 168 151 35 34
CLONIDINE HCL 167 164 36 45
SINGULAIR 165 165 37 78
ADVAIR DISKUS 161 157 38 51
METOPROLOL TARTRATE 159 156 39 11
TRIAMCINOLONE ACETONIDE 157 154 40 133
AMOXICILLIN 156 154 41 111
FLUOCINONIDE 153 135 42 249
LOSARTAN-HYDROCHLOROTHIAZIDE 142 134 43 40
POTASSIUM CHLORIDE 137 136 44 19
NIFEDIPINE ER 134 133 45 114
JANUVIA 132 120 46 66
EXFORGE 131 131 47 208
COLCRYS 130 125 48 159
PROAIR HFA 130 115 48 49
MELOXICAM 130 130 48 56
AVODART 128 128 51 194
AMOX TR-POTASSIUM CLAVULANATE 126 106 52 142
LEVOTHYROXINE SODIUM 122 106 53 4
NASONEX 119 108 54 218
PATADAY 116 114 55 268
AMLODIPINE BESYLATE-BENAZEPRIL 116 113 55 70
MECLIZINE HCL 115 113 57 115
GLIPIZIDE 113 113 58 47
HYDROCODONE-ACETAMINOPHEN 105 96 S3 59 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 103 81 60 26
CLOTRIMAZOLE-BETAMETHASONE 102 90 61 174
CHLORHEXIDINE GLUCONATE 102 102 61 285
TRAMADOL HCL 100 81 63 18
VIREAD 100 86 63 382
BENICAR 99 98 65 181
LACTULOSE 99 99 65 108
NABUMETONE 99 93 65 201
TOBRAMYCIN-DEXAMETHASONE 99 92 65 383
DICLOFENAC SODIUM 97 97 69 103
VYTORIN 96 82 70 191
BARACLUDE 94 91 71 384
HYDROXYZINE HCL 92 90 R 72 168
DONEPEZIL HCL 91 91 73 24
HYDROCHLOROTHIAZIDE 90 90 74 9
MONTELUKAST SODIUM 90 86 74 149
LOVASTATIN 90 87 74 36
IBUPROFEN 89 81 77 80
GABAPENTIN 85 82 78 16
VERAPAMIL ER 83 83 79 91
MICARDIS HCT 81 81 80 343
CARVEDILOL 77 66 81 20
BENICAR HCT 73 73 82 211
EVISTA 72 72 83 154
JANUMET 71 71 84 233
ONGLYZA 70 62 85 214
NITROSTAT 70 68 85 180
PREDNISONE 69 63 87 39
HALOBETASOL PROPIONATE 68 63 88 408
DICLOFENAC POTASSIUM 66 63 89 414
KETOCONAZOLE 65 64 90 217
PROCTOSOL-HC 62 61 91 420
TRAMADOL HCL-ACETAMINOPHEN 62 62 91 189
GLIPIZIDE XL 60 60 93 124
DILTIAZEM 24HR CD 59 59 94 101
VALSARTAN-HYDROCHLOROTHIAZIDE 59 58 94 344
TEKTURNA 57 53 96 433
LYRICA 57 57 96 127
AZOR 57 57 96 337
ENALAPRIL MALEATE 56 56 99 73
EXELON 56 56 99 164
SPIRIVA 56 51 99 57
NIFEDIAC CC 55 49 102 319
FAMOTIDINE 54 54 103 75
LEVOXYL 53 53 104 139
WARFARIN SODIUM 53 53 104 12
CARBIDOPA-LEVODOPA 52 52 106 107
HUMALOG MIX 75-25 50 50 107 237
NIFEDICAL XL 50 50 107 255
MEGESTROL ACETATE 50 48 R 107 185
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 21, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.